Quipt Home Medical Revenue Growth Rates (QIPT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Quipt Home Medical Corp   (NASDAQ: QIPT)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

QIPT's Revenue Growth by Quarter and Year

Quipt Home Medical 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QIPT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter September -
3rd Quarter June -
2nd Quarter March -
1st Quarter December 81.00
FY 81.00

QIPTs Annual Revenue
Quipt Home Medical 's Revenue in the fiscal year 2025 $ 245.36 millions
Quipt Home Medical 's Revenue in the fiscal year 2024 $ 245.92 millions
Quipt Home Medical 's Revenue in the fiscal year 2023 $ 211.68 millions
Quipt Home Medical 's Revenue in the fiscal year 2022 $ 139.86 millions
Quipt Home Medical 's Revenue in the fiscal year 2021 $ 102.35 millions




QIPT Revenue first quarter 2026 Y/Y Growth Comment
Quipt Home Medical Corp achieved in the first quarter 2026, above Company average Revenue growth of 31.96% year on year, to $ 81.00 millions.

According to the results reported in the first quarter 2026, Quipt Home Medical Corp achieved the best Revenue growth in Healthcare Facilities industry. While Quipt Home Medical Corp ' s Revenue rise of 31.96% ranks overall at the positon no. 446 in the first quarter 2026.


QIPT Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter September - -72.22 % - -
3rd Quarter June - -4.07 % - -
2nd Quarter March - -6.32 % - -
1st Quarter December 31.96 % -1.9 % - -
FY   - -43.01 % - -

Financial Statements
Quipt Home Medical 's first quarter 2026 Revenue $ 81.00 millions QIPT's Income Statement
Quipt Home Medical 's first quarter 2025 Revenue $ 61.38 millions Quarterly QIPT's Income Statement


QIPT Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter September - 17.19 % 304.74 % -
3rd Quarter June - 1.59 % -0.8 % -
2nd Quarter March - -6.52 % -2.11 % -
1st Quarter December 18.57 % -75.04 % - -
FY (Year on Year)   - -43.01 % - -


Back to QIPT Growth rate Comparisons >> Back to QIPT Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #29
Overall #446

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #29
Overall #446
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Quipt Home Medical 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
18.57 % -8.84 % -75.04 %
(Dec 31 2025)  


QIPT's I. Quarter Q/Q Revenue Comment
Quipt Home Medical Corp achieved in the I. Quarter 2026 above company average sequential Revenue jump of 18.57%, to $ 81.00 millions, from $68.31 millions in the fourth quarter.
QIPT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry Quipt Home Medical Corp achieved highest sequential Revenue growth. While Quipt Home Medical 's Revenue growth quarter on quarter, overall rank is 60.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #0
Healthcare Sector #2
Overall #60
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #0
Healthcare Sector #2
Overall #60
Revenue Q/Q Growth Statistics
High Average Low
18.57 % -8.84 % -75.04 %
(Dec 31 2025)  


QIPT's I. Quarter Q/Q Revenue Comment
Quipt Home Medical Corp achieved in the I. Quarter 2026 above company average sequential Revenue jump of 18.57%, to $ 81.00 millions, from $68.31 millions in the fourth quarter.
QIPT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry Quipt Home Medical Corp achieved highest sequential Revenue growth. While Quipt Home Medical 's Revenue growth quarter on quarter, overall rank is 60.


Quipt Home Medical 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)
Cumulative Revenue 12 Months Ending $ 264.97 $ 245.36 $ 422.96 $ 425.43 $ 429.31
Y / Y Revenue Growth (TTM) -38.28 % -43.01 % - - -
Year on Year Revenue Growth Overall Ranking # 3950 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 7.99 % -41.99 % -0.58 % -0.9 % -0.28 %
Seq. Revenue Growth (TTM) Overall Ranking # 2851 # 3073 # 3032 # 0 # 0


Cumulative Revenue growth Comment
Quipt Home Medical showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2025. If the fiscal year would end in Dec 31 2025, Quipt Home Medical 's annual Revenue decline would be -38.28% year on year to $265 millions.

In the Healthcare sector 523 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3950.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 524
Overall # 3950

Revenue TTM Y/Y Growth Statistics
High Average Low
-38.28 %
 -40.64 %
-43.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 396
S&P 500 # 2851
Cumulative Revenue growth Comment
Quipt Home Medical showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2025. If the fiscal year would end in Dec 31 2025, Quipt Home Medical 's annual Revenue drop would be -38.28% year on year to $265 millions.

In the Healthcare sector 523 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3950.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 28
Healthcare Sector # 524
Overall # 3950

Revenue TTM Y/Y Growth Statistics
High Average Low
-38.28 %
-40.64 %
-43.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 28
Sector # 396
S&P 500 # 2851




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
QIPT's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Ideaya Biosciences Inc 55.37%$ 55.371 millions
Urogen Pharma Ltd 54.03%$ 54.028 millions
The Pennant Group Inc 53.17%$ 53.168 millions
Halozyme Therapeutics Inc 51.60%$ 51.596 millions
Nephros Inc 51.08%$ 51.084 millions
Adaptive Biotechnologies Corporation51.04%$ 51.038 millions
Mirum Pharmaceuticals Inc 49.81%$ 49.810 millions
Ascendis Pharma A49.14%$ 49.137 millions
Hyperfine Inc 48.82%$ 48.824 millions
Intelligent Bio Solutions Inc 47.62%$ 47.619 millions
Gossamer Bio Inc 47.13%$ 47.127 millions
Electrocore Inc 46.11%$ 46.111 millions
Mannkind Corporation45.82%$ 45.820 millions
Hologic Inc44.84%$ 44.836 millions
Ensysce Biosciences Inc 44.39%$ 44.389 millions
Profound Medical Corp 43.13%$ 43.127 millions
Regenxbio Inc 43.00%$ 43.005 millions
Xeris Biopharma Holdings Inc 42.78%$ 42.776 millions
Eli Lilly And Company42.56%$ 42.557 millions
Edwards Lifesciences Corporation42.48%$ 42.484 millions
Rani Therapeutics Holdings Inc 42.12%$ 42.121 millions
Establishment Labs Holdings Inc 41.85%$ 41.854 millions
The Oncology Institute Inc 41.58%$ 41.579 millions
Cytosorbents Corporation41.55%$ 41.553 millions
Vystar Corporation41.19%$ 41.186 millions
Prelude Therapeutics Inc41.00%$ 41.000 millions
Biodesix Inc 40.76%$ 40.756 millions
Ligand Pharmaceuticals Incorporated40.01%$ 40.008 millions
Femasys Inc 39.84%$ 39.844 millions
Natera Inc 39.79%$ 39.793 millions


About Quipt Home Medical Revenue Growth Rates (QIPT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Quipt Home Medical Corp (CIK 1540013).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001104659-26-012059
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Quipt Home Medical Corp ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.